Medium- and Large-Vessel Vasculitis

被引:103
|
作者
Saadoun, David [1 ,2 ,3 ]
Vautier, Mathieu [1 ]
Cacoub, Patrice [2 ,3 ]
机构
[1] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Assistance Publ Hopitaux Paris AP HP,Ctr Natl Ref, Dept Internal Med & Clin Immunol,Ctr Natl Referen, Paris, France
[2] Inst Natl Sante & Rech Med INSERM, Unite Mixte Rech UMR S 959, Paris, France
[3] Rech Hosp Univ Sante RHU Interleukin, Therapy Autoimmune & Inflammatory Dis 2, Paris, France
关键词
giant cell arteritis; Kawasaki disease; polyarteritis nodosa; Takayasu; vasculitis;
D O I
10.1161/CIRCULATIONAHA.120.046657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic vasculitides are multisystem blood vessel disorders, which are defined by the size of the vessel predominantly affected, namely small, medium, or large vessels. The term "large vessel" relates to the aorta and its major branches; "medium vessel" refers to the main visceral arteries and veins and their initial branches. The most common causes of large-vessel vasculitis are giant cell arteritis and Takayasu arteritis, and those of medium-vessel arteritis are polyarteritis nodosa and Kawasaki disease. However, there is some overlap, and arteries of any size can potentially be involved in any of the 3 main categories of dominant vessel involvement. In addition to multisystem vasculitides, other forms of vasculitis have been defined, including single-organ vasculitis (eg, isolated aortitis). Prompt identification of vasculitides is important because they are associated with an increased risk of mortality. Left undiagnosed or mismanaged, these conditions may result in serious adverse outcomes that might otherwise have been avoided or minimized. The ethnic and regional differences in the incidence, prevalence, and clinical characteristics of patients with vasculitis should be recognized. Because the clinical presentation of vasculitis is highly variable, the cardiovascular clinician must have a high index of suspicion to establish a reliable and prompt diagnosis. This article reviews the pathophysiology, epidemiology, diagnostic strategies, and management of vasculitis.
引用
收藏
页码:267 / 282
页数:16
相关论文
共 50 条
  • [21] Large-vessel vasculitis in a cardiac allograft
    Bader, F
    Upadya, S
    Sokol, S
    Azimi, N
    Katz, SD
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (09) : 745 - 745
  • [22] Relapsing Polychondritis and Large-vessel Vasculitis
    D'Cruz, David P.
    Ferrada, Marcela A.
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (12) : 1732 - 1733
  • [23] The bias in the nomenclature of large-vessel vasculitis
    Mukhtyar, Chetan B.
    RHEUMATOLOGY, 2023, 62 (04) : E124 - E126
  • [24] Large-vessel vasculitis induced by pegfilgrastim
    Silva, Costa R.
    Monteiro, M.
    Dias, R. P.
    Silva, I
    dos Santos, Rodrigues J.
    Vassalo, T.
    Martins, Rosa J.
    Leite, I
    Abreu, C.
    Martins-Martinho, J.
    Ponte, C.
    Romeu, Carlos J.
    Peixoto, L.
    ACTA REUMATOLOGICA PORTUGUESA, 2021, 46 (04): : 355 - 359
  • [25] Chronic periaortitis: a large-vessel vasculitis?
    Vaglio, Augusto
    Pipitone, Nicolo
    Salvarani, Carlo
    CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (01) : 1 - 6
  • [26] Multimodality imaging of large-vessel vasculitis
    Tarkin, Jason M.
    Gopalan, Deepa
    HEART, 2023, 109 (03) : 232 - 240
  • [27] FDG PET Imaging of Large-Vessel Vasculitis
    Cao, Qi
    Chen, Wengan
    PET CLINICS, 2012, 7 (02) : 227 - 232
  • [28] ANGIOGRAPHIC PROGRESSION OF DISEASE IN LARGE-VESSEL VASCULITIS
    Quinn, K. A.
    Dashora, H.
    Ahlman, M.
    Grayson, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1064 - 1065
  • [29] Efficacy of baricitinib for refractory large-vessel vasculitis
    Regent, Alexis
    Terrier, Benjamin
    Legendre, Paul
    Wartski, Myriam
    Cohen, Pascal
    Mouthon, Luc
    Le Jeunne, Claire
    RHEUMATOLOGY, 2021, 60 (11) : E389 - E391
  • [30] Angiographic Progression of Disease in Large-Vessel Vasculitis
    Quinn, Kaitlin
    Dashora, Himanshu
    Ahlman, Mark
    Novakovich, Elaine
    Grayson, Peter C.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72